Improving lung cancer screening for African Americans
Addressing racial disparities in lung cancer screening
This study is working to create a tool that helps African Americans understand their risk for lung cancer so they can get screened more fairly, since current guidelines mostly focus on white populations.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11043383 on NIH RePORTER |
What this research studies
This research aims to address the racial disparities in lung cancer screening by developing a personalized risk prediction tool specifically for African Americans. Current screening guidelines are based on data that primarily reflects white populations, leading to reduced eligibility for African Americans. By analyzing data from large-scale cohorts with significant African American representation, the research will create a more equitable assessment of lung cancer risk and eligibility for screening. The study will involve constructing a natural-history model of lung cancer risk and evaluating various screening strategies through simulations.
Who could benefit from this research
Good fit: Ideal candidates for this research include African American individuals who are at risk for lung cancer based on age and smoking history.
Not a fit: Patients who do not identify as African American or who do not meet the risk criteria for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more equitable lung cancer screening practices, ultimately improving early detection and survival rates for African Americans.
How similar studies have performed: Other research has shown success in developing personalized risk models for different populations, indicating that this approach could be effective for addressing disparities in lung cancer screening.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Aldrich, Melinda — Vanderbilt University Medical Center
- Study coordinator: Aldrich, Melinda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.